112 related articles for article (PubMed ID: 21720707)
1. Expression of CLDN1 in colorectal cancer: a novel marker for prognosis.
Nakagawa S; Miyoshi N; Ishii H; Mimori K; Tanaka F; Sekimoto M; Doki Y; Mori M
Int J Oncol; 2011 Oct; 39(4):791-6. PubMed ID: 21720707
[TBL] [Abstract][Full Text] [Related]
2. SCRN1 is a novel marker for prognosis in colorectal cancer.
Miyoshi N; Ishii H; Mimori K; Sekimoto M; Doki Y; Mori M
J Surg Oncol; 2010 Feb; 101(2):156-9. PubMed ID: 20039278
[TBL] [Abstract][Full Text] [Related]
3. Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma.
Chao YC; Pan SH; Yang SC; Yu SL; Che TF; Lin CW; Tsai MS; Chang GC; Wu CH; Wu YY; Lee YC; Hong TM; Yang PC
Am J Respir Crit Care Med; 2009 Jan; 179(2):123-33. PubMed ID: 18787218
[TBL] [Abstract][Full Text] [Related]
4. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
[TBL] [Abstract][Full Text] [Related]
5. The significance of PITX2 overexpression in human colorectal cancer.
Hirose H; Ishii H; Mimori K; Tanaka F; Takemasa I; Mizushima T; Ikeda M; Yamamoto H; Sekimoto M; Doki Y; Mori M
Ann Surg Oncol; 2011 Oct; 18(10):3005-12. PubMed ID: 21479692
[TBL] [Abstract][Full Text] [Related]
6. Expression of KITENIN in human colorectal cancer and its relation to tumor behavior and progression.
Lee S; Song YA; Park YL; Cho SB; Lee WS; Lee JH; Chung IJ; Kim KK; Rew JS; Joo YE
Pathol Int; 2011 Apr; 61(4):210-20. PubMed ID: 21418393
[TBL] [Abstract][Full Text] [Related]
7. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
8. Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1.
Zhao L; Wang H; Liu C; Liu Y; Wang X; Wang S; Sun X; Li J; Deng Y; Jiang Y; Ding Y
Gut; 2010 Sep; 59(9):1226-35. PubMed ID: 20660701
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of EGFL8: a novel prognostic biomarker for patients with colorectal cancer.
Wu F; Shirahata A; Sakuraba K; Kitamura Y; Goto T; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
Anticancer Res; 2011 Jun; 31(6):2249-54. PubMed ID: 21737648
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of UNC5B expression in colorectal cancer.
Okazaki S; Ishikawa T; Iida S; Ishiguro M; Kobayashi H; Higuchi T; Enomoto M; Mogushi K; Mizushima H; Tanaka H; Uetake H; Sugihara K
Int J Oncol; 2012 Jan; 40(1):209-16. PubMed ID: 21922135
[TBL] [Abstract][Full Text] [Related]
11. Neuropilin-1 is involved in regulation of apoptosis and migration of human colon cancer.
Ochiumi T; Kitadai Y; Tanaka S; Akagi M; Yoshihara M; Chayama K
Int J Oncol; 2006 Jul; 29(1):105-16. PubMed ID: 16773190
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of BMP7 in human colorectal cancer.
Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous expression of claudin-4 in human colorectal cancer: decreased claudin-4 expression at the invasive front correlates cancer invasion and metastasis.
Ueda J; Semba S; Chiba H; Sawada N; Seo Y; Kasuga M; Yokozaki H
Pathobiology; 2007; 74(1):32-41. PubMed ID: 17496431
[TBL] [Abstract][Full Text] [Related]
14. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H
Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108
[TBL] [Abstract][Full Text] [Related]
15. TGM2 is a novel marker for prognosis and therapeutic target in colorectal cancer.
Miyoshi N; Ishii H; Mimori K; Tanaka F; Hitora T; Tei M; Sekimoto M; Doki Y; Mori M
Ann Surg Oncol; 2010 Apr; 17(4):967-72. PubMed ID: 20033322
[TBL] [Abstract][Full Text] [Related]
16. Overexpression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in colorectal cancer.
Kim KS; Kim JT; Lee SJ; Kang MA; Choe IS; Kang YH; Kim SY; Yeom YI; Lee YH; Kim JH; Kim KH; Kim CN; Kim JW; Nam MS; Lee HG
Clin Chim Acta; 2013 Jan; 415():12-9. PubMed ID: 22975528
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of Claudin family genes in colorectal cancer in a Chinese population.
Tang W; Dou T; Zhong M; Wu Z
Biofactors; 2011; 37(1):65-73. PubMed ID: 21294205
[TBL] [Abstract][Full Text] [Related]
18. Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer.
Jiang Z; Wang Z; Xu Y; Wang B; Huang W; Cai S
Biosci Rep; 2010 Dec; 30(6):383-90. PubMed ID: 20001967
[TBL] [Abstract][Full Text] [Related]
19. TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition.
Jung H; Lee KP; Park SJ; Park JH; Jang YS; Choi SY; Jung JG; Jo K; Park DY; Yoon JH; Park JH; Lim DS; Hong GR; Choi C; Park YK; Lee JW; Hong HJ; Kim S; Park YW
Oncogene; 2008 Apr; 27(18):2635-47. PubMed ID: 17968309
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of osteoprotegerin expression in human colorectal cancer.
Tsukamoto S; Ishikawa T; Iida S; Ishiguro M; Mogushi K; Mizushima H; Uetake H; Tanaka H; Sugihara K
Clin Cancer Res; 2011 Apr; 17(8):2444-50. PubMed ID: 21270110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]